Clinical Commentary on ‘Late-Onset Neutropenia and Neurological Relapse During Long-Term Rituximab Therapy in MOG Antibody Spectrum Disorder’

Multiple Sclerosis - United States
doi 10.1177/1352458518775245
Full Text
Abstract

Available in full text

Categories
Neurology
Date
Authors
Publisher

SAGE Publications

Related search

Late-Onset Neutropenia After Rituximab Treatment for Adult-Onset Nephrotic Syndrome

Case Reports in Nephrology
2019English

Clinical Features in Very Early-Onset Demyelinating Disease With Anti-Mog Antibody

Brain and Development
Child HealthDevelopmental NeurosciencePerinatologyNeurologyMedicinePediatrics
2017English

Rituximab-Related Late-Onset Neutropenia in Patients With Rheumatic Diseases: Successful Re-Challenge of the Treatment

American Journal of Case Reports
Medicine
2015English

Lymphocyte Subpopulation Imbalances, Bone Marrow Hematopoiesis and Histopathology in Rituximab-Treated Lymphoma Patients With Late-Onset Neutropenia

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2008English

Rituximab-Related Late-Onset Neutropenia After Autologous Stem Cell Transplantation for Aggressive Non-Hodgkin's Lymphoma

Bone Marrow Transplantation
TransplantationHematology
2004English

Short-Term Immunopathological Changes Associated With Pulse Steroids/Ivig/Rituximab Therapy in Late Kidney Allograft Antibody Mediated Rejection

Kidney360
2020English

Adding Cognitive Therapy to Minimal Psychiatric Care Prevents Short Term, but Not Long Term, Relapse in People With Bipolar Disorder

Evidence-Based Mental Health
PsychiatryMental Health
2005English

Late-Onset Neuromyelitis Optica Spectrum Disorder in AQP4-seropositive Patients in a Chinese Population

BMC Neurology
MedicineNeurology
2015English

MOG Antibody-Associated Diseases

Neurology: Neuroimmunology and NeuroInflammation
Neurology
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy